Autopsy report · NCT05359835

DTPA (Diethylenetriaminepenta-acetate) Chelation for Symptoms After Gadolinium-assisted MRI Exposure

“Could not recruit subjects quickly enough”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Stanford University

Sponsor type

University, hospital or other

Conditions

Gadolinium Deposition Disease

Interventions

Calcium DTPA and Zinc DTPA

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Vitamin D Versus Placebo in the Treatment of Vague Musculoskeletal Pain in Children
  “inability to recruit subjects” (84% match in meaning)
• In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
  “Not able to recruit subjects” (84% match in meaning)
• Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
  “Unable to recruit any subjects” (82% match in meaning)
• Prospective Evaluation of Symptom Resolution in Acid Versus Non-acid Reflux Disease Following Anti-reflux Surgery
  “Unable to recruit a sufficient number of subjects.” (82% match in meaning)
• Recombinant Human Prolactin for Lactation Induction
  “Not able to recruit any subjects.” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.